Letter to the editor regarding article : Impact of COVID-19 outbreak on lifestyle behaviour: A review of studies published in India (Rawat et al.)
| Errataetall: |
CommentOn: Diabetes Metab Syndr. 2021 Jan-Feb;15(1):331-336. - PMID 33493852 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Diabetes & metabolic syndrome - 15(2021), 3 vom: 07. Mai, Seite 1053-1054 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mirzaei, Fatemeh [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.06.2021 Date Revised 23.06.2021 published: Print-Electronic CommentOn: Diabetes Metab Syndr. 2021 Jan-Feb;15(1):331-336. - PMID 33493852 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.dsx.2021.04.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324486545 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324486545 | ||
| 003 | DE-627 | ||
| 005 | 20231225190426.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.dsx.2021.04.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1081.xml |
| 035 | |a (DE-627)NLM324486545 | ||
| 035 | |a (NLM)33895088 | ||
| 035 | |a (PII)S1871-4021(21)00125-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mirzaei, Fatemeh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Letter to the editor regarding article |b Impact of COVID-19 outbreak on lifestyle behaviour: A review of studies published in India (Rawat et al.) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.06.2021 | ||
| 500 | |a Date Revised 23.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Diabetes Metab Syndr. 2021 Jan-Feb;15(1):331-336. - PMID 33493852 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Alcohol | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Smoking | |
| 700 | 1 | |a Tavilani, Alireza |e verfasserin |4 aut | |
| 700 | 1 | |a Abbasi-Oshaghi, Ebrahim |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes & metabolic syndrome |d 2007 |g 15(2021), 3 vom: 07. Mai, Seite 1053-1054 |w (DE-627)NLM189445564 |x 1878-0334 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2021 |g number:3 |g day:07 |g month:05 |g pages:1053-1054 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.dsx.2021.04.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2021 |e 3 |b 07 |c 05 |h 1053-1054 | ||